PROCTER & GAMBLE HEALTH | ELDER PHARMA | PROCTER & GAMBLE HEALTH/ ELDER PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | -1.0 | - | View Chart |
P/BV | x | 10.6 | 0.1 | 10,504.1% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH ELDER PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ELDER PHARMA Jun-14 |
PROCTER & GAMBLE HEALTH/ ELDER PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 380 | 1,412.0% | |
Low | Rs | 3,883 | 188 | 2,065.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 489.2 | 151.4% | |
Earnings per share (Unadj.) | Rs | 138.2 | -3.2 | -4,347.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 14.4 | 1,076.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 376.5 | 118.9% | |
Shares outstanding (eoy) | m | 16.60 | 20.54 | 80.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.6 | 1,075.5% | |
Avg P/E ratio | x | 33.5 | -89.3 | -37.5% | |
P/CF ratio (eoy) | x | 29.8 | 19.7 | 151.2% | |
Price / Book Value ratio | x | 10.3 | 0.8 | 1,369.8% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 5,832 | 1,316.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 2,179 | 94.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 10,048 | 122.4% | |
Other income | Rs m | 184 | 257 | 71.7% | |
Total revenues | Rs m | 12,480 | 10,305 | 121.1% | |
Gross profit | Rs m | 3,247 | 2,921 | 111.2% | |
Depreciation | Rs m | 281 | 361 | 77.8% | |
Interest | Rs m | 8 | 2,756 | 0.3% | |
Profit before tax | Rs m | 3,142 | 60 | 5,249.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 125 | 677.0% | |
Profit after tax | Rs m | 2,295 | -65 | -3,513.6% | |
Gross profit margin | % | 26.4 | 29.1 | 90.8% | |
Effective tax rate | % | 27.0 | 209.1 | 12.9% | |
Net profit margin | % | 18.7 | -0.6 | -2,871.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 9,240 | 126.8% | |
Current liabilities | Rs m | 6,791 | 9,998 | 67.9% | |
Net working cap to sales | % | 40.0 | -7.5 | -530.8% | |
Current ratio | x | 1.7 | 0.9 | 186.6% | |
Inventory Days | Days | 263 | 128 | 204.9% | |
Debtors Days | Days | 343 | 602 | 57.1% | |
Net fixed assets | Rs m | 10,617 | 13,642 | 77.8% | |
Share capital | Rs m | 166 | 206 | 80.7% | |
"Free" reserves | Rs m | 7,265 | 7,528 | 96.5% | |
Net worth | Rs m | 7,431 | 7,733 | 96.1% | |
Long term debt | Rs m | 0 | 4,889 | 0.0% | |
Total assets | Rs m | 22,330 | 22,882 | 97.6% | |
Interest coverage | x | 409.1 | 1.0 | 40,035.7% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 125.4% | |
Return on assets | % | 10.3 | 11.8 | 87.7% | |
Return on equity | % | 30.9 | -0.8 | -3,656.9% | |
Return on capital | % | 42.4 | 22.3 | 190.0% | |
Exports to sales | % | 0 | 3.1 | 0.0% | |
Imports to sales | % | 13.1 | 0.4 | 3,043.6% | |
Exports (fob) | Rs m | NA | 307 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 43 | 3,724.8% | |
Fx inflow | Rs m | 1,465 | 307 | 477.9% | |
Fx outflow | Rs m | 1,605 | 125 | 1,281.6% | |
Net fx | Rs m | -140 | 181 | -77.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 11,754 | 20.1% | |
From Investments | Rs m | -215 | -561 | 38.4% | |
From Financial Activity | Rs m | -985 | -6,762 | 14.6% | |
Net Cashflow | Rs m | 1,160 | 5,466 | 21.2% |
Indian Promoters | % | 0.0 | 25.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 24.0 | 83.3% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 74.7 | 64.5% | |
Shareholders | 56,778 | 31,548 | 180.0% | ||
Pledged promoter(s) holding | % | 0.0 | 77.6 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Elder Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.18% | 4.97% | 0.97% |
1-Month | -0.72% | 21.21% | 2.08% |
1-Year | -0.85% | -64.54% | 55.37% |
3-Year CAGR | -8.62% | -51.65% | 15.04% |
5-Year CAGR | 5.02% | -37.46% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Elder Pharma share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Elder Pharma the stake stands at 25.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Elder Pharma.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Elder Pharma.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.